Friday, 24 August 2018 09:02

ASM Joins Clinical Laboratory Organizations to Express PAMA Concerns to Congress

ASM joined organizations representing laboratories, diagnostic manufacturers, health care professionals, and patients to urge Congress to take immediate action to address the harmful cuts to the Clinical Laboratory Fee Schedule (CLFS). The cuts to the CLFS are now in effect because of the flawed implementation of the Protecting Access to Medicare Act (PAMA). Without action by Congress, PAMA may create serious health care access and public health issues for patients because of lack of access to clinical laboratory services, patients risk missed or delayed diagnoses. Read the letter.